Skip to content

FDA product code · Cardiovascular

DXNSystem, Measurement, Blood-Pressure, Non-Invasive

Product code DXN covers System, Measurement, Blood-Pressure, Non-Invasive, a Class II device regulated under 21 CFR 870.1130. FDA has cleared 1,219 devices in this code, 27 of them in the last 12 months. Median review time across the 1,219 most recent decisions is 110 days. openFDA lists 36 recall records against this code.

Updated · ingest status · JSON

Class
Class II
Regulation
21 CFR 870.1130
Review panel
Cardiovascular
Clearances
1,219

What is happening in DXN right now?

DXN (System, Measurement, Blood-Pressure, Non-Invasive) has three findings, most consequential first. 8 first-time filers in the last 12 months, including Guangzhou Daxin Health Technology Co., Ltd. and 80 Beats Medical GmbH (K261136, K260693, K253059, K253124, K253152). Clearances are running 35% slower — a median 148 days over the last 12 months against 110 days all-time (elapsed calendar days, not FDA review days) (DXN:review_time:12m). The code is crowded, scoring 100 of 100 — 445 companies hold a clearance here and 27 arrived in the last 12 months (DXN:crowding).

Every factor behind the statement above, most consequential first, with the FDA records it came from.
FindingHow much it mattersFDA records
New entrantWorth knowingK261136, K260693, K253059, K253124, K253152
Review timeContextDXN:review_time:12m
CrowdingContextDXN:crowding

Sources checked: predicate ancestry, recalls, adverse events, new entrants, review time, crowding. Composed . Every finding carries the record ids it was derived from; nothing here is an estimate.

How many devices has FDA cleared in DXN?

FDA has cleared 1,219 devices under product code DXN since the 510(k) programme began in 1976, 27 of them in the last 12 months.

Source: openFDA device/510k · retrieved

Most recent 510(k) clearances in DXN, newest first.
510(k)DeviceApplicantDecision
K261136Blood Pressure Monitor (M501,M501A,M502,M502A,M502C,M502D)Guangzhou Daxin Health Technology Co., Ltd.
K261082Microlife Wrist Blood Pressure Monitor , (Model BPHJG5-G)Microlife Corporation
K253126Wrist Blood Pressure Monitor (XW-05)Shenzhen Ziqing Medical Equipment Co., Ltd.
K260693VicorderCS (VCS-SYS-1100)80 Beats Medical GmbH
K253059Tournicare ARMA Automatic Blood Pressure Monitor (ARMA-08)Tournicare Pty, Ltd.
K253124Upper arm electronic blood pressure monitor (XB-01)Shenzhen Ziqing Medical Equipment Co., Ltd.
K253570Blood Pressure Monitor (W06LT)Shenzhen Jamr Technology Co., Ltd.
K254048Wrist Watch Electronic Blood Pressure Monitor (U16H, U16L, U16P, U16W, U19M, U19R, U19S, and U19T)Shenzhen Urion Technology Co., Ltd.
K253152BP1000 Ultra-Compact Fingertip Blood Pressure Monitor (BP1000)Biozen, LLC
K260260Automatic Digital Blood Pressure Monitor (LD-587, LD-528, LD-562, LD-581, LD-521, LD-527, LD-572 & LD-569)Honsun (Nantong) Co., Ltd.

How long does FDA review take for DXN?

The median FDA review time for DXN is 110 days, measured across the 1,219 most recent decisions with both a received date and a decision date.

Review time here is decision date minus date received, as published by FDA. It is elapsed calendar time, not FDA review days — the two differ whenever the agency stops the clock for an additional information request.

Source: openFDA device/510k · retrieved

Are there recalls in DXN?

openFDA lists 36 recall records against product code DXN. A recall record covers one firm's corrective action and may span many device lots.

  • Z-1508-2025Open, ClassifiedPYRAMES INC

    Single-use battery-powered blood pressure monitor, for use on neonates and infants, due to vibratory noise, may not adequately detect changes in blood pressure per specification. Containment actions: 1) Ventilator lines not to touch the isolette (e.g. mattress, side rails, pillow) or patient, 2) Move affected monitor to patient's foot.

  • Z-0032-2025Open, ClassifiedMEDLINE INDUSTRIES, LP - Northfield

    It has been determined that certain Blood Pressure Monitors containing a faulty microchip have failed to power on or have shown display screen issues after the initial few uses, as well as overheating at times making the unit warm to the touch.

  • Z-0033-2025Open, ClassifiedMEDLINE INDUSTRIES, LP - Northfield

    It has been determined that certain Blood Pressure Monitors containing a faulty microchip have failed to power on or have shown display screen issues after the initial few uses, as well as overheating at times making the unit warm to the touch.

  • Z-0034-2025Open, ClassifiedMEDLINE INDUSTRIES, LP - Northfield

    It has been determined that certain Blood Pressure Monitors containing a faulty microchip have failed to power on or have shown display screen issues after the initial few uses, as well as overheating at times making the unit warm to the touch.

  • Z-1509-2024Open, ClassifiedBaxter Healthcare Corporation

    Baxter received reports of an issue related to the construction of the power cord not meeting the insulation rating per country-specific requirements and international electrical standards.

Showing the 5 most recently initiated of 36. Recall class comes from openFDA's enforcement endpoint, which does not carry every recall — where it is missing, none is shown rather than guessed. Status is FDA's own wording; a terminated recall is a closed one, and the total spans the code's whole history, not just what is open today.

Source: openFDA device/recall · retrieved

How many adverse events are reported for DXN?

MAUDE holds 705 adverse-event reports naming product code DXN, 150 of them received in the last 12 months.

MAUDE reports are submitted by manufacturers, importers, user facilities and the public. They are unverified, and a report is not proof that the device caused the event.

Source: openFDA device/event · retrieved

Is adverse-event reporting in DXN unusual?

Every month with enough history behind it falls inside DXN's own expected range. Nothing here is unusual for this code.

Monthly adverse-event reports naming DXN, against the expected range computed from this code's own history. Shaded band is the expected range; a bar above it is the month flagged. Retrieved 11 August 2026.
Reports received per month for DXN, with the expected range and whether the month fell outside it.
MonthReportsExpectedVerdict
12Insufficient historyNo expected range — too little history
12Insufficient historyNo expected range — too little history
19Insufficient historyNo expected range — too little history
11Insufficient historyNo expected range — too little history
17Insufficient historyNo expected range — too little history
14Insufficient historyNo expected range — too little history
16Insufficient historyNo expected range — too little history
13Insufficient historyNo expected range — too little history
7Insufficient historyNo expected range — too little history
12Insufficient historyNo expected range — too little history
13Insufficient historyNo expected range — too little history
22Insufficient historyNo expected range — too little history
15Insufficient historyNo expected range — too little history
9Insufficient historyNo expected range — too little history
9Insufficient historyNo expected range — too little history
32Insufficient historyNo expected range — too little history
12Insufficient historyNo expected range — too little history
12Insufficient historyNo expected range — too little history
103Insufficient historyNo expected range — too little history
20Insufficient historyNo expected range — too little history
11Insufficient historyNo expected range — too little history
90–69Within expected (0–69)
130–56Within expected (0–56)
220–62Within expected (0–62)
210–65Within expected (0–65)
590–61Within expected (0–61)
140–81Within expected (0–81)
190–118Within expected (0–118)
270–84Within expected (0–84)
70–88Within expected (0–88)
50–83Within expected (0–83)
250–48Within expected (0–48)
180–57Within expected (0–57)
260–65Within expected (0–65)
190–55Within expected (0–55)
250–60Within expected (0–60)

21 months do not have a full, unbroken year of history before them, so no expected range is shown for those. Insufficient history is reported as insufficient rather than as zero: an empty baseline would turn a gap in our data into a spike. Method: ewma_alpha_0.3_sd_2 corpus_adjusted. Counts are divided by the corpus-wide volume for that month before comparison, so a rise across all of MAUDE is not reported as a rise in DXN.

Who has entered DXN in the last year?

8 companies filed in DXN for the first time in the last 12 months.

First-time filers in DXN within the last 12 months, with the clearance that marks their entry.
CompanyFirst clearedK-number
Guangzhou Daxin Health Technology Co., Ltd.K261136
80 Beats Medical GmbHK260693
Tournicare Pty, Ltd.K253059
Shenzhen Ziqing Medical Equipment Co., Ltd.K253124
Biozen, LLCK253152
Beijing Hanvon Health Technology Co., Ltd.K253982
Shenzhen HanHan Technology Co., Ltd.K254225
Ningbo Ranor Medical Technology Co., Ltd.K253142

"First time" means their first clearance in this product code, not their first ever — an established manufacturer entering a new category is exactly the movement worth knowing about.

Source: openFDA device/510k · retrieved

What are the predicate devices in DXN?

FDA publishes no machine-readable predicate field, so no predicate chain is recorded for this code yet.

A predicate chain matters because a device inherits the safety history of what it was compared to. FDA publishes the chain only inside each 510(k) summary PDF, never as data — so where we have edges, they are read from those documents, and where we do not, we say so instead of showing an empty list.

Who files 510(k)s in DXN?

Across the 1,219 most recent decisions, these applicants filed most often in DXN.

Most frequent applicants in DXN among recent decisions.
ApplicantRecent clearances
Andon Health Co, Ltd.68
Health & Life Co., Ltd.55
Omron Healthcare, Inc.36
Microlife Intellectual Property GmbH33
A&D Engineering, Inc.25

Applicant names above are exactly as FDA published them, so one company can appear under several spellings.

Source: openFDA device/510k · retrieved

Watch DXN

Get an email the morning anything changes in DXN — a new clearance, a recall, or an adverse-event spike above this code's own baseline.

Start watching DXN

Data on this page comes from FDA's public openFDA API and is US public domain (CC0). DeviceSignal is an independent commercial service and is not affiliated with the U.S. Food and Drug Administration. Information only, not regulatory advice. Verify anything you rely on against open.fda.gov.